Adagio Medical Holdings, Inc. (ADGM)
0.882
-0.06
(-5.97%)
USD |
NASDAQ |
Jan 13, 16:00
0.89
+0.01
(+0.91%)
After-Hours: 20:00
Adagio Medical Holdings Research and Development Expense (Quarterly): 2.274M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Standard BioTools, Inc. | 6.356M |
| LENSAR, Inc. | 1.367M |
| Intelligent Bio Solutions, Inc. | 0.4862M |
| Movano, Inc. | 1.166M |
| NeuroPace, Inc. | 6.576M |